Yatharth Hospital board to discuss growth plans and fund raising on Sep 17

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Board meeting scheduled for September 17, 2026, to review growth strategies
  • Company may raise funds via debt, equity, or hybrid securities
  • Trading window closed for insiders until 48 hours post-meeting
  • Expansion plans subject to regulatory approvals and board terms
powered bylight_fuzz_icon
50927339

*this image is generated using AI for illustrative purposes only.

Yatharth Hospital & Trauma Care Services Limited has scheduled a board meeting for September 17, 2026, to discuss growth plans and potential fund raising. The company is exploring various modes of capital infusion to support its expansion strategy.

The meeting agenda includes considering proposals to raise funds through debt, rights issues, preferential allotments, or qualified institutions placements. The board may also evaluate issuing equity shares, warrants, or other convertible securities in accordance with the Companies Act, 2013, and SEBI regulations.

Regulatory Compliance

In compliance with Regulation 29(1)(d) of the SEBI Listing Regulations, the company issued this intimation to the National Stock Exchange and BSE Limited. The trading window for designated persons and their immediate relatives remains closed until 48 hours after the conclusion of the board meeting.

Operational Footprint

The company operates hospitals across multiple locations in North India, including facilities in Greater Noida, Noida, Faridabad, New Delhi, Agra, and Orchha. These centers form the core of its trauma care and hospital services network.

Historical Stock Returns for Yatharth Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-1.12%+0.42%+7.52%+41.81%+21.08%0.0%

How might the chosen method of capital infusion impact existing shareholders' equity and voting power?

Will the raised funds be primarily allocated to expanding the current North Indian footprint or entering new geographic markets?

What is the expected timeline for the completion of the fundraising process following the board meeting on September 17, 2026?

Yatharth Hospital faces ₹29.66 Cr tax demand from Delhi authorities

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Yatharth Hospital faces a ₹29.66 crore tax demand plus ₹11.42 crore interest from Delhi authorities
  • Subsidiaries AKS Medical and Ramraja face additional demands of ₹8.50 crore and ₹5.64 crore respectively
  • Assessment proceedings cover AY 2014-15 to AY 2024-25 for the parent company
  • Company plans to file appeals before CIT (Appeals) seeking substantial relief
  • No financial provision made as management expects significant reduction in demands
powered bylight_fuzz_icon
50924196

*this image is generated using AI for illustrative purposes only.

Yatharth Hospital and two of its subsidiaries have received final income tax assessment orders from the Deputy Commissioner of Income Tax, Central Circle-28, Delhi. The orders result in aggregate demands totaling ₹29.66 crore plus interest for the parent company.

The tax proceedings cover assessment years from AY 2014-15 to AY 2024-25 for Yatharth Hospital. Subsidiaries AKS Medical & Research Centre Private Limited and Ramraja Multispeciality Hospital & Trauma Centre Private Limited also face demands.

Breakdown of Tax Demands

The total liability includes principal amounts and interest across the three entities. The assessment proceedings for the specified years are now concluded at this level.

Entity Principal Demand Interest Demand Assessment Years
Yatharth Hospital ₹29.66 crore ₹11.42 crore AY 2014-15 to AY 2024-25
AKS Medical ₹8.50 crore ₹2.48 crore AY 2022-23 to AY 2024-25
Ramraja Multispeciality ₹5.64 crore ₹2.04 crore AY 2023-24

Appeal Strategy

Following advice from external tax consultants, the company and its subsidiaries are filing appeals before the CIT (Appeals). Management expects these proceedings to yield significant reductions in the demanded amounts.

What the Numbers Show

The interest component represents a material portion of the total liability. For the parent company, interest of ₹11.42 crore constitutes approximately 28% of the combined demand of ₹41.08 crore. This highlights the cost of prolonged assessment periods spanning over a decade.

Financial Impact

Based on internal assessments, the company believes no provision is currently required in its financial statements. It remains confident of obtaining substantial relief through the appellate process.

Historical Stock Returns for Yatharth Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-1.12%+0.42%+7.52%+41.81%+21.08%0.0%

How might the ₹41.08 crore total liability impact Yatharth Hospital's cash flow and liquidity ratios if the appeals are not successful?

What is the typical timeline for CIT (Appeals) proceedings in India, and how will this prolonged uncertainty affect the company's operational planning?

Could this tax dispute signal broader compliance risks for other subsidiaries or future acquisitions within the Yatharth group?

More News on Yatharth Hospital

1 Year Returns:+21.08%